Kashmir-grown stigmas
The crimson stigmas are the material recognized as saffron and the botanical basis of the Safralis specification.
Safralis starts with Kashmir-grown Crocus sativus stigmas and a specification built around saffron's characteristic compounds: 7.5% crocins and 4% Safranals. Each listed compound is measured separately, giving your team a clear ingredient at either 15mg or 30mg.
Botanical starting point
Published saffron research commonly evaluates Crocus sativus stigma and its characteristic chemistry. Safralis uses only crimson stigmas sourced from Kashmir, giving the ingredient a clear botanical identity from the start.
The crimson stigmas are the material recognized as saffron and the botanical basis of the Safralis specification.
Safralis contains no flower extract. Petals and tepals may produce more extract, but they are not the material Safralis is designed to standardize.
The source and plant part are documented on the specification, then checked lot by lot for botanical identity.
Research-guided specification
Crocins, safranal, and picrocrocin are among the characteristic compounds most often described in saffron research. Safralis turns that chemistry into a specification your team can evaluate directly: 7.5% crocins and 4% Safranals, with each listed compound measured separately.
Color compounds
Water-soluble carotenoids that give saffron its characteristic color and contribute to its bioactive profile.
Aroma compounds and precursors
The 4% specification covers Safranal, Picrocrocin, and HTCC—the compounds and precursors behind saffron's distinctive aroma.
Identity and quantification
HPTLC confirms botanical identity. UPLC measures each compound listed on the specification separately.
HPTLC compares the sample's chromatographic fingerprint with authentic Crocus sativus stigma.
UPLC measures crocins and each Safranals compound against the 7.5% and 4% specifications.
At the stated specification, 15mg corresponds to 1.125mg crocins and 0.60mg Safranals; 30mg corresponds to 2.25mg crocins and 1.20mg Safranals.
Research-led product directions
Safralis can lead a focused saffron product or strengthen a broader formula at either 15mg or 30mg.
A familiar direction for formulas centered on positive mood and emotional balance.*
A complementary position for mental clarity, calm focus, and cognitive support.*
A broader platform for products focused on healthy neurological function.*
A supporting role in antioxidant and healthy-aging formulas.*
A differentiated direction for products focused on healthy appetite and mindful eating.*
Safralis was developed from the chemistry outward: choose the right plant part, define the compounds, and verify every lot. Safralis-specific human studies are the planned next step.
Research context: The applications above reflect published research on saffron and its constituents, not clinical studies of Safralis. Safralis-specific human studies are planned. *Any finished-product claim must be substantiated for the final formula and intended market. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Commercial formulation
The low serving weight leaves room for Safralis to lead a focused saffron product or sit alongside other actives in a broader formula.
Capsules, tablets, dry powders, and combination formulas.
Use as the lead saffron ingredient or alongside complementary actives.
The specification, representative COA, and analytical reports are available for review.
From Kashmir to your specification
A concise view of the information your team can review before purchasing.
Kashmir sourcing documented on the specification.
Crocus sativus stigma only; no flower extract.
7.5% crocins and 4% Safranals, with each compound named.
HPTLC confirms botanical identity.
UPLC measures each specified compound separately.
Sample, qualification documents, and formulation support available.
Technical profile
Review the core specification here, then request the complete documentation package for your R&D and quality teams.
| Attribute | Specification |
|---|---|
| Botanical identity | Crocus sativus L. |
| Origin | Kashmir saffron |
| Plant part | Stigma |
| Ingredient form | Bulk powder for dietary supplement formulas |
| Crocins | 7.5% |
| Safranals | 4% as Safranal, Picrocrocin, and HTCC |
| Identity method | HPTLC |
| Quantitative method | UPLC |
| Suggested dosage | 15mg or 30mg per serving |
| Declared compounds at 15mg | 1.125mg crocins; 0.60mg Safranals |
| Declared compounds at 30mg | 2.25mg crocins; 1.20mg Safranals |
| Intended application | Finished dietary supplements |
| Clinical status | Safralis-specific human studies are planned |
Buyer qualification
Request a sample, the complete specification, representative analytical documents, pricing, or direct formulation support.
Commercial evaluation
Tell us what you are developing and what your team needs to evaluate Safralis.